146 related articles for article (PubMed ID: 35259410)
1. Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
Whitehouse KC; Shochet T; Lohr PA
Contraception; 2022 Jun; 110():21-26. PubMed ID: 35259410
[TBL] [Abstract][Full Text] [Related]
2. Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.
Dabash R; Shochet T; Hajri S; Chelli H; Hassairi AE; Haleb D; Labassi H; Sfar E; Temimi F; Koenig L; Winikoff B
BMC Womens Health; 2016 Jul; 16():49. PubMed ID: 27475998
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
Fok WK; Lerma K; Shaw KA; Blumenthal PD
Contraception; 2021 Sep; 104(3):296-300. PubMed ID: 33992610
[TBL] [Abstract][Full Text] [Related]
5. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
[TBL] [Abstract][Full Text] [Related]
6. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
Hassoun D; Périn I; Hiên H; Demars HH
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308
[TBL] [Abstract][Full Text] [Related]
8. Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.
Paul M; Iyengar K; Iyengar S; Gemzell-Danielsson K; Essén B; Klingberg-Allvin M
BMC Womens Health; 2014 Aug; 14():98. PubMed ID: 25127545
[TBL] [Abstract][Full Text] [Related]
9. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
Raymond EG; Shochet T; Blum J; Sheldon WR; Platais I; Bracken H; Dabash R; Weaver MA; Ngoc NTN; Blumenthal PD; Winikoff B
Contraception; 2017 May; 95(5):442-448. PubMed ID: 28041991
[TBL] [Abstract][Full Text] [Related]
10. "False positive" urine pregnancy test results after successful medication abortion.
Raymond EG; Anger HA; Chong E; Haskell S; Grant M; Boraas C; Tocce K; Banks J; Kaneshiro B; Baldwin MK; Coplon L; Bednarek P; Shochet T; Platais I
Contraception; 2021 Jun; 103(6):400-403. PubMed ID: 33596414
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of self-assessment of gestational duration among people seeking abortion.
Ralph LJ; Ehrenreich K; Barar R; Biggs MA; Morris N; Blanchard K; Kapp N; Moayedi G; Perritt J; Raymond EG; White K; Grossman D
Am J Obstet Gynecol; 2022 May; 226(5):710.e1-710.e21. PubMed ID: 34922922
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of telephone follow-up after medical abortion.
Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
[TBL] [Abstract][Full Text] [Related]
13. Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
Anger HA; Raymond EG
Contraception; 2023 Aug; 124():110055. PubMed ID: 37088124
[TBL] [Abstract][Full Text] [Related]
14. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Warden S; Genkin I; Hum S; Dunn S
J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
[TBL] [Abstract][Full Text] [Related]
15. Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.
Hsia JK; Lohr PA; Taylor J; Creinin MD
Contraception; 2019 Sep; 100(3):178-181. PubMed ID: 31102629
[TBL] [Abstract][Full Text] [Related]
16. Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.
Raymond EG; Shochet T; Bracken H
Contraception; 2018 Jul; 98(1):30-35. PubMed ID: 29534996
[TBL] [Abstract][Full Text] [Related]
17. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
[TBL] [Abstract][Full Text] [Related]
18. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.
Platais I; Tsereteli T; Comendant R; Kurbanbekova D; Winikoff B
Contraception; 2015 Feb; 91(2):178-83. PubMed ID: 25497383
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist provision of medication abortion: A pilot study.
Sandoval S; Rafie S; Kully G; Mody S; Averbach S
Contraception; 2024 Mar; 131():110346. PubMed ID: 38065286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
